Effectiveness of rifampicin-soaked vascular graft as an treatment for infective aneurysm

Effectiveness of rifampicin-soaked vascular graft as an treatment for infective aneurysm - Effectiveness of rifampicin-soaked vascular graft as an treatment for infective aneurysm

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012885

Enrollment

Registered

2014-01-17

Start date

2014-01-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective aortic aneurysm

Interventions

vascular graft is soaked in rifampin solution before implantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) patients with infective aortic aneurysm diagnosed with imaging study and/or laboratory study (2) refractory to medical treatment

Exclusion criteria

Exclusion criteria: (1)age younger than 20 years (2)patients with allgery to rifampicin (3) patients who refuse to the study

Design outcomes

Primary

Measure	Time frame
clinical control of infection, operative death	—

Countries

Japan

Contacts

Public ContactKenji Minakata

Kyoto University Graduate School of Medicine Cardiovascular Surgery

minakata@kuhp.kyoto-u.ac.jp075-751-3780

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026